TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06463340: Study of SGR-3515 In Participants With Advanced Solid Tumors.

Sponsor: Schrödinger, Inc. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 52 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$1,727,880

Rescue Site Savings

+$1,130,976

Unlock Full NCT06463340 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06463340 Rescue Dossier →